Ngā hua rapu - Tange, Hiroya

  • E whakaatu ana i te 1 - 3 hua o te 3
Whakamahine hua
  1. 1
    Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice

    Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice mā Ishibashi, Daisuke, Ishikawa, Takeshi, Mizuta, Satoshi, Tange, Hiroya, Nakagaki, Takehiro, Hamada, Tsuyoshi, Nishida, Noriyuki

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Liquid–liquid phase separation of full-length prion protein initiates conformational conversion in vitro

    Liquid–liquid phase separation of full-length prion protein initiates conformational conversion in vitro mā Tange, Hiroya, Ishibashi, Daisuke, Nakagaki, Takehiro, Taguchi, Yuzuru, Kamatari, Yuji O., Ozawa, Hiroki, Nishida, Noriyuki

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice

    Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice mā Nakagaki, Takehiro, Ishibashi, Daisuke, Mori, Tsuyoshi, Miyazaki, Yukiko, Takatsuki, Hanae, Tange, Hiroya, Taguchi, Yuzuru, Satoh, Katsuya, Atarashi, Ryuichiro, Nishida, Noriyuki

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: